{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:39:19Z","timestamp":1784770759423,"version":"3.55.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.imlet.2025.107002","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T01:43:11Z","timestamp":1742434991000},"page":"107002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Autoantibodies and therapeutic antibodies against complement factor H"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3709-1526","authenticated-orcid":false,"given":"Saskia","family":"Nugteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-4385","authenticated-orcid":false,"given":"Haiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-0899","authenticated-orcid":false,"given":"Cees","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-032X","authenticated-orcid":false,"given":"Kyra A.","family":"Gelderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-2290","authenticated-orcid":false,"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0001","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol. Rev."},{"issue":"Pt 1","key":"10.1016\/j.imlet.2025.107002_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bst0320021","article-title":"Proteases of the complement system","volume":"32","author":"Sim","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.imlet.2025.107002_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2021.12.001","article-title":"The role of properdin and Factor H in disease","volume":"153","author":"Cortes","year":"2022","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"Sj\u00f6berg","year":"2009","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0007","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.imlet.2025.107002_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldl004","article-title":"Atypical haemolytic uraemic syndrome","volume":"77-78","author":"Kavanagh","year":"2006","journal-title":"Br. Med. Bull."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0009","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1007\/s00018-021-03796-9","article-title":"The complement system in age-related macular degeneration","volume":"78","author":"Armento","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies against complement components and functional consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol. Immunol."},{"issue":"2-3","key":"10.1016\/j.imlet.2025.107002_bib0011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0161-5890(01)00043-8","article-title":"Autoantibodies to complement components","volume":"38","author":"Trouw","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0012","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fimmu.2019.00886","article-title":"Nephritic factors: an overview of classification, diagnostic tools and clinical associations","volume":"10","author":"Corvillo","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14712598.5.2.243","article-title":"Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis","volume":"5","author":"Trouw","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"50","key":"10.1016\/j.imlet.2025.107002_bib0014","first-page":"120","article-title":"Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation","author":"Dijkstra","year":"2023","journal-title":"Proc. National Acad. Sci."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies","volume":"12","author":"Durey","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The factor H protein family: the switchers of the complement alternative pathway","volume":"313","author":"Lucientes-Continente","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2025.107002_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101341","article-title":"Regulation of regulators: role of the complement factor H-related proteins","volume":"45","author":"Cserhalmi","year":"2019","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molimm.2015.03.011","article-title":"Of mice and men: the factor H protein family and complement regulation","volume":"67","author":"Pouw","year":"2015","journal-title":"Mol. Immunol."},{"issue":"39","key":"10.1016\/j.imlet.2025.107002_bib0019","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack","volume":"282","author":"Trouw","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0021","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0014-5793(99)01554-9","article-title":"Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin","volume":"462","author":"Hellwage","year":"1999","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0022","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.174.10.6250","article-title":"Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein","volume":"174","author":"McRae","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2025.107002_bib0023","doi-asserted-by":"crossref","first-page":"e78617","DOI":"10.1371\/journal.pone.0078617","article-title":"Human factor H-related protein 2 (CFHR2) regulates complement activation","volume":"8","author":"Eberhardt","year":"2013","journal-title":"PLoS. One"},{"issue":"23","key":"10.1016\/j.imlet.2025.107002_bib0024","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","article-title":"An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)","volume":"19","author":"Fritsche","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0025","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2025.107002_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1135490","article-title":"The human factor H protein family - an update","volume":"15","author":"S\u00e1ndor","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0027","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"23","key":"10.1016\/j.imlet.2025.107002_bib0028","doi-asserted-by":"crossref","first-page":"19528","DOI":"10.1074\/jbc.M112.364471","article-title":"Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein","volume":"287","author":"Hebecker","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0029","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.4049\/jimmunol.1403121","article-title":"Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation","volume":"194","author":"Csincsi","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4049\/jimmunol.1600483","article-title":"FHR-1 binds to C-reactive protein and enhances rather than inhibits complement activation","volume":"199","author":"Csincsi","year":"2017","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0031","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1681\/ASN.2015020212","article-title":"Complement factor H-related 5-hybrid proteins anchor properdin and activate complement at self-surfaces","volume":"27","author":"Chen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imlet.2025.107002_bib0032","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3389\/fimmu.2020.01297","article-title":"Interaction of the factor H family proteins FHR-1 and FHR-5 with DNA and dead cells: implications for the regulation of complement activation and opsonization","volume":"11","author":"K\u00e1rp\u00e1ti","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0033","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.molimm.2009.12.005","article-title":"Molecular basis of c-reactive protein binding and modulation of complement activation by factor H-related protein 4","volume":"47","author":"Hebecker","year":"2010","journal-title":"Mol. Immunol."},{"issue":"21","key":"10.1016\/j.imlet.2025.107002_bib0034","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.imlet.2025.107002_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914496","article-title":"Underlying genetics of aHUS: which connection with outcome and treatment discontinuation?","volume":"24","author":"Spasiano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0036","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imlet.2025.107002_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01282","article-title":"Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database","volume":"10","author":"Puraswani","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0038","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2025.107002_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607211","article-title":"Factor H autoantibodies and complement-mediated diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0040","doi-asserted-by":"crossref","first-page":"e60352","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0041","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.kint.2017.04.028","article-title":"Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland","volume":"92","author":"Brocklebank","year":"2017","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2011.152","article-title":"Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome","volume":"80","author":"Strobel","year":"2011","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.imlet.2025.107002_bib0043","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome","volume":"189","author":"Blanc","year":"2012","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.imlet.2025.107002_bib0044","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1074\/jbc.M114.630871","article-title":"The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease","volume":"290","author":"Bhattacharjee","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00467-018-4074-4","article-title":"Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome","volume":"34","author":"Guo","year":"2019","journal-title":"Pediatric Nephrol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0046","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti\u2013factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"J\u00f3zsi","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0047","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/gfp388","article-title":"Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome","volume":"25","author":"Strobel","year":"2010","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0048","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.2020081224","article-title":"IgM autoantibodies to complement factor H in atypical hemolytic uremic syndrome","volume":"32","author":"Cugno","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0049","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.1200357","article-title":"Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor H and factor H-related protein 1 to pentraxin 3","volume":"189","author":"Kopp","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molimm.2015.12.005","article-title":"Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome","volume":"70","author":"Nozal","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0051","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3389\/fimmu.2018.01727","article-title":"Reference intervals of factor H and factor H-related proteins in healthy children","volume":"9","author":"van Beek","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0052","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.ajkd.2015.03.039","article-title":"Distal angiopathy and atypical hemolytic uremic syndrome: clinical and functional properties of an anti-factor H IgA\u03bb antibody","volume":"66","author":"Rigothier","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0053","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"J\u00f3zsi","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.imlet.2025.107002_bib0054","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J. Med. Genet."},{"issue":"19","key":"10.1016\/j.imlet.2025.107002_bib0055","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H\u2013related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0056","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1203\/PDR.0b013e3181b1bd4a","article-title":"Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1\/CFHR3 deficiency","volume":"66","author":"Lee","year":"2009","journal-title":"Pediatr. Res."},{"issue":"06","key":"10.1016\/j.imlet.2025.107002_bib0057","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0030-1262884","article-title":"The autoimmune disease DEAP-hemolytic uremic syndrome","volume":"36","author":"Skerka","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0058","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0059","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/imm.12916","article-title":"Characterization of genetic predisposition and autoantibody profile in atypical haemolytic\u2013uraemic syndrome","volume":"154","author":"Gurjar","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2025.107002_bib0060","first-page":"10","article-title":"Rare functional variants in complement genes and Anti-FH autoantibodies-associated aHUS","author":"Valoti","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0061","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00467-021-05390-4","article-title":"Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection","volume":"37","author":"Khandelwal","year":"2022","journal-title":"Pediatric Nephrol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0062","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000513009","article-title":"Clinical and genetic characteristics of atypical hemolytic uremic syndrome in children: a Chinese cohort study","volume":"145","author":"Wu","year":"2021","journal-title":"Nephron."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0063","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/ndt\/gfp166","article-title":"Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases","volume":"24","author":"Kwon","year":"2009","journal-title":"Nephrol. Dial. TransPlant"},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/41169409-3260-4295-baf4-a1a4621a8e48","article-title":"Microbes bind complement inhibitor factor H via a common site","volume":"9","author":"Meri","year":"2013","journal-title":"PLoS. Pathog."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp Antibody Responses and the Antibodies Enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.imlet.2025.107002_bib0066","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00467-022-05862-1","article-title":"Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome","volume":"38","author":"Khandelwal","year":"2023","journal-title":"Pediatric Nephrol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0067","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ki.2011.399","article-title":"Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion","volume":"81","author":"Sethi","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0068","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/ndt\/gfs288","article-title":"Idiopathic membranoproliferative glomerulonephritis: does it exist?","volume":"27","author":"Fervenza","year":"2012","journal-title":"Nephrol. Dial. TransPlant"},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0069","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10238-018-0491-8","article-title":"The role of the alternative pathway of complement activation in glomerular diseases","volume":"18","author":"\u0141ukawska","year":"2018","journal-title":"Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.imlet.2025.107002_bib0071","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2025.107002_bib0072","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2215\/CJN.00320121","article-title":"C3 Glomerulopathy and Related Disorders in Children","volume":"16","author":"Wong","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0073","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40620-019-00672-5","article-title":"Outcome of C3 glomerulopathy patients: largest single-centre experience from South Asia","volume":"33","author":"Kumar","year":"2020","journal-title":"J. Nephrol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0074","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ckj\/sfz135","article-title":"Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy","volume":"14","author":"Kumar","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3-4","key":"10.1016\/j.imlet.2025.107002_bib0076","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0077","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0078","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2025.107002_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720183","article-title":"FHR-5 serum levels and CFHR5 genetic variations in patients with immune complex-mediated membranoproliferative glomerulonephritis and c3-glomerulopathy","volume":"12","author":"Garam","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ckj\/sfs002","article-title":"Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease","volume":"5","author":"Nozal","year":"2012","journal-title":"Clin. Kidney J."},{"issue":"11","key":"10.1016\/j.imlet.2025.107002_bib0081","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0082","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am. J. Kidney Diseases"},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0083","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s40620-024-01961-4","article-title":"IgM autoantibodies to complement factor H in C3 glomerulopathy","volume":"37","author":"Cugno","year":"2024","journal-title":"J. Nephrol."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0084","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/ndt\/gfr422","article-title":"Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis","volume":"26","author":"Brackman","year":"2011","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"20","key":"10.1016\/j.imlet.2025.107002_bib0085","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0086","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0087","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"16","key":"10.1016\/j.imlet.2025.107002_bib0088","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1056\/NEJMc1905608","article-title":"More about factor H autoantibodies in membranous nephropathy","volume":"381","author":"Valoti","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0089","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2215\/CJN.16631020","article-title":"Limited significance of antifactor H antibodies in patients with membranous nephropathy","volume":"16","author":"Sethi","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"25","key":"10.1016\/j.imlet.2025.107002_bib0090","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1056\/NEJMc1805857","article-title":"Factor H autoantibodies and membranous nephropathy","volume":"379","author":"Seikrit","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0091","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5414\/CN110479","article-title":"Association between anti-complement factor H antibodies and renal outcome in primary membranous nephropathy","volume":"96","author":"Kagaya","year":"2021","journal-title":"Clin. Nephrol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0092","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.kint.2016.03.042","article-title":"Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective","volume":"90","author":"Hoover","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2025.107002_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101339","article-title":"Complement activation and regulation in rheumatic disease","volume":"45","author":"Dijkstra","year":"2019","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0094","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrrheum.2017.125","article-title":"The complement system as a potential therapeutic target in rheumatic disease","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2025.107002_bib0096","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0097","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/096120339400300417","article-title":"Primary', 'secondary' and other variants of the antiphospholipid syndrome","volume":"3","author":"Asherson","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2025.107002_bib0098","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molimm.2022.08.011","article-title":"Overview on the role of complement-specific autoantibodies in diseases","volume":"151","author":"Matola","year":"2022","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0099","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2249.2003.02274.x","article-title":"Autoantibodies against mannose-binding lectin in systemic lupus erythematosus","volume":"134","author":"Seelen","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0100","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4016","article-title":"Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome","volume":"14","author":"Foltyn Zadura","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0101","first-page":"11","article-title":"Impact of autoantibodies to complement components on the disease activity in SLE","volume":"69","author":"Pradhan","year":"2021","journal-title":"J. Assoc. Physicians India"},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0102","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/rheumatology\/kes218","article-title":"Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis","volume":"51","author":"Wang","year":"2012","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1016\/j.imlet.2025.107002_bib0103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2018.02.142","article-title":"Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome","volume":"164","author":"Nakamura","year":"2018","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0104","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3899\/jrheum.150185","article-title":"Factor H autoantibodies in patients with antiphospholipid syndrome and thrombosis","volume":"42","author":"Foltyn Zadura","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2025.107002_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2024.05.019","article-title":"Anti-factor H autoantibodies in patients with lupus nephritis","author":"Mihaylova","year":"2024","journal-title":"Med. Clin. (Barc)"},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0037-1612904","article-title":"Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins","volume":"85","author":"Rampazzo","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.imlet.2025.107002_bib0107","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350832","article-title":"Autoantibodies against complement proteins in patients with antiphospholipid syndrome: prevalence and clinical associations","volume":"54","author":"Philip","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2020.05.005","article-title":"Anti-complement factor H autoantibodies may be protective in lupus nephritis","volume":"508","author":"Li","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0109","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.4049\/jimmunol.136.9.3407","article-title":"Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2","volume":"136","author":"Kristensen","year":"1986","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12026-023-09396-y","article-title":"Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis","volume":"71","author":"Li","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2025.107002_bib0111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1447991","article-title":"Factor H-related protein 1 in systemic lupus erythematosus","volume":"15","author":"Kleer","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13730-021-00627-5","article-title":"Thrombotic microangiopathy in a patient with systemic lupus erythematosus and anti-factor H autoantibodies","volume":"11","author":"Figueiredo","year":"2022","journal-title":"CEN. Case Rep."},{"issue":"7","key":"10.1016\/j.imlet.2025.107002_bib0113","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"42","key":"10.1016\/j.imlet.2025.107002_bib0114","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2025.107002_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1113015","article-title":"Autoantibodies against complement factor B in rheumatoid arthritis","volume":"14","author":"Matola","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.imlet.2025.107002_bib0118","first-page":"15","article-title":"Emerging targeted therapies in advanced non-small-cell lung cancer","author":"Li","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0119","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1158\/1078-0432.CCR-10-0321","article-title":"Complement factor H autoantibodies are associated with early stage NSCLC","volume":"16","author":"Amornsiripanitch","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.imlet.2025.107002_bib0120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/2326-6066.CIR-15-0122","article-title":"Complement factor h antibodies from lung cancer patients induce complement-dependent lysis of tumor cells, suggesting a novel immunotherapeutic strategy","volume":"3","author":"Campa","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0121","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/1535-7163.MCT-22-0723","article-title":"Antitumor immune mechanisms of the anti-complement factor H antibody GT103","volume":"22","author":"Bushey","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0122","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/CBM-210355","article-title":"Prognostic significance of a complement factor H autoantibody in early stage NSCLC","volume":"34","author":"Gottlin","year":"2022","journal-title":"Cancer Biomark"},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0123","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2328433","article-title":"Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression","volume":"13","author":"Revel","year":"2024","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0124","first-page":"20","article-title":"Molecular docking and molecular dynamics (MD) simulation of human anti-complement factor H (CFH) antibody Ab42 and CFH polypeptide","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2025.107002_bib0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.imlet.2025.107002_bib0126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660382","article-title":"Autoantibodies against the complement regulator factor H in the serum of patients with neuromyelitis optica spectrum disorder","volume":"12","author":"Uzonyi","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0127","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1002\/ajh.26868","article-title":"Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C)","volume":"98","author":"Zerra","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107002_bib0128","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/apa.17267","article-title":"Multisystem inflammatory syndrome in children: a review","volume":"113","author":"Benvenuto","year":"2024","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.imlet.2025.107002_bib0129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.imlet.2025.107002_bib0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00109-022-02190-7","article-title":"Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19","volume":"100","author":"Veraldi","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.imlet.2025.107002_bib0131","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.726949","article-title":"Case report: endothelial glycocalyx damage in critically ill patients with SARS-CoV-2-related multisystem inflammatory syndrome (MIS-C)","volume":"9","author":"Fern\u00e1ndez-Sarmiento","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.imlet.2025.107002_bib0132","first-page":"2080","article-title":"Copy number variation in the complement factor H-related genes and age-related macular degeneration","volume":"17","author":"Kubista","year":"2011","journal-title":"Mol. Vis."},{"issue":"11","key":"10.1016\/j.imlet.2025.107002_bib0133","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1167\/iovs.09-5124","article-title":"Complement factor h autoantibodies and age-related macular degeneration","volume":"51","author":"Dhillon","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5728","key":"10.1016\/j.imlet.2025.107002_bib0134","first-page":"1592","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science (1979)"},{"key":"10.1016\/j.imlet.2025.107002_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842451","article-title":"Circulating levels of anti-C1q and anti-factor h autoantibodies and their targets in normal pregnancy and preeclampsia","volume":"13","author":"Dijkstra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0136","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/637513","article-title":"Interleukin-15 (IL-15) and anti-C1q antibodies as serum biomarkers for ectopic pregnancy and missed abortion","volume":"2013","author":"Daponte","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imlet.2025.107002_bib0137","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaut.2016.06.012","article-title":"Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2025.107002_bib0138","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1302490","article-title":"Complement factor H: a novel innate immune checkpoint in cancer immunotherapy","volume":"12","author":"Saxena","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"17","key":"10.1016\/j.imlet.2025.107002_bib0139","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1074\/jbc.275.17.12917","article-title":"Mechanistic studies of the effects of anti-factor H antibodies on complement-mediated lysis","volume":"275","author":"Corey","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41467-024-55092-2","article-title":"Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial","volume":"16","author":"Clarke","year":"2025","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.imlet.2025.107002_bib0141","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.2300728","article-title":"Promotion of an antitumor immune program by a tumor-specific, complement-activating antibody","volume":"212","author":"Saxena","year":"2024","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107002_bib0142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179841","article-title":"Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody","volume":"12","author":"Winkler","year":"2017","journal-title":"PLoS. One"},{"issue":"7","key":"10.1016\/j.imlet.2025.107002_bib0143","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.celrep.2016.04.038","article-title":"A therapeutic antibody for cancer, derived from single human B cells","volume":"15","author":"Bushey","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107002_bib0144","article-title":"Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107002_bib0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/bloodadvances.2018025692","article-title":"Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera","volume":"3","author":"Pouw","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0146","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","article-title":"The role of complement in kidney disease: conclusions from a Kidney Disease: Improving global outcomes (KDIGO) controversies conference","volume":"106","author":"Vivarelli","year":"2024","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.imlet.2025.107002_bib0147","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: improving global outcomes\" (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.imlet.2025.107002_bib0148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the factor H autoantibody assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2025.107002_bib0149","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4939-8949-2_15","article-title":"Anti-factor H Autoantibodies assay by ELISA","volume":"1901","author":"S\u00e9nant","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imlet.2025.107002_bib0150","article-title":"Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance","volume":"15","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:30:47Z","timestamp":1744345847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":150,"alternative-id":["S0165247825000343"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies and therapeutic antibodies against complement factor H","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107002"}}